HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Marketing In Brief

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Avon: Anew Ultimate Eye Cream and Anew Ultimate Hand & Nail Cream SPF 15 UVA/UVB extend firm's anti-aging treatment line, direct-seller announces. Bowing in July, eye cream contains exclusive Ultimate Eye Fusion Complex formulated with freshwater pearl, caviar, deep moisturizers and vitamins, Avon says. Item will retail for $22 for 15 mL. Hand & Nail Cream is formulated with Ultimate Fusion Complex containing gold, copper, magnesium and silk, according to firm. Hand & Nail Cream will be available in September and retail at $15 for 75 mL...

Table

View full table

Tags:
Latest Headlines

Partisan Politics Returns To US FDA Congressional Oversight

The Aspirin Test For AI?

Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News

Clasado, Probi Funded Study Shows Synergistic Effect Of Synbiotic Combination

See All
UsernamePublicRestriction

Register

RS011193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By